| Cash Flow | 2025-07-25 | 2025-01-24 | 2024-10-25 | 2024-07-26 |
|---|---|---|---|---|
| Stock-based compensation | 86 | 340 | 242 | 83 |
| Provision for credit losses | 28 | 96 | 45 | 18 |
| Net income | 1,047 | 3,630 | 2,327 | 1,049 |
| Other, net | -159 | -14 | 98 | 9 |
| Other operating assets and liabilities | 464 | 685 | 800 | 194 |
| Inventories | 373 | 478 | 278 | 217 |
| Accounts payable and accrued liabilities | -598 | -157 | -707 | -604 |
| Accounts receivable, net | -288 | 184 | 181 | -110 |
| Depreciation and amortization | 748 | 2,021 | 1,337 | 662 |
| Deferred income taxes | 167 | -81 | 57 | 88 |
| Net cash provided by operating activities | 1,088 | 4,516 | 1,944 | 986 |
| Sales and maturities of investments | 2,010 | 6,255 | 4,338 | 2,157 |
| Additions to property, plant, and equipment | 504 | 1,400 | 924 | 520 |
| Purchases of investments | 2,100 | 6,093 | 4,019 | 1,879 |
| Acquisitions, net of cash acquired | - | 98 | 0 | - |
| Other investing activities, net | 125 | 111 | -1 | 17 |
| Net cash used in investing activities | -719 | -1,447 | -604 | -259 |
| Payments on long-term debt | 1,162 | - | - | - |
| Change in current debt obligations, net | 649 | -1,070 | -67 | -624 |
| Other financing activities, net | 70 | 96 | -64 | -15 |
| Issuance of ordinary shares | 95 | 400 | 232 | 89 |
| Issuance of long-term debt | 0 | 3,209 | 3,209 | 3,209 |
| Dividends to shareholders | 910 | 2,692 | 1,795 | 898 |
| Repurchase of ordinary shares | 123 | 2,961 | 2,780 | 2,492 |
| Net cash used in financing activities | -1,381 | -3,018 | -1,265 | -731 |
| Effect of exchange rate changes on cash and cash equivalents | 67 | -95 | 35 | 31 |
| Net change in cash and cash equivalents | -945 | -44 | 110 | 27 |
Medtronic plc (MDT)
Medtronic plc (MDT)